Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Association between physical activity and postoperative complications after esophagectomy for cancer: a prospective observational study.

Tatematsu N, Park M, Tanaka E, Sakai Y, Tsuboyama T.

Asian Pac J Cancer Prev. 2013;14(1):47-51.

2.

Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial).

van der Sluis PC, Ruurda JP, van der Horst S, Verhage RJ, Besselink MG, Prins MJ, Haverkamp L, Schippers C, Rinkes IH, Joore HC, Ten Kate FJ, Koffijberg H, Kroese CC, van Leeuwen MS, Lolkema MP, Reerink O, Schipper ME, Steenhagen E, Vleggaar FP, Voest EE, Siersema PD, van Hillegersberg R.

Trials. 2012 Nov 30;13:230. doi: 10.1186/1745-6215-13-230.

3.
4.

Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial.

Li B, Xiang J, Zhang Y, Li H, Zhang J, Sun Y, Hu H, Miao L, Ma L, Luo X, Chen S, Ye T, Zhang Y, Zhang Y, Chen H.

JAMA Surg. 2015 Apr;150(4):292-8. doi: 10.1001/jamasurg.2014.2877.

PMID:
25650816
5.

Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer.

Nishigori T, Okabe H, Tanaka E, Tsunoda S, Hisamori S, Sakai Y.

J Surg Oncol. 2016 May;113(6):678-84. doi: 10.1002/jso.24214. Epub 2016 Mar 3.

PMID:
26936808
6.

Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.

Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N.

Am J Surg. 2005 Jan;189(1):98-109.

PMID:
15701501
7.

[Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].

Wu J, Chai Y, Zhou XM, Chen QX, Yan FL.

Ai Zheng. 2007 Mar;26(3):307-11. Chinese.

PMID:
17355797
8.

Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?

Shim YM, Park JS, Lee M, Kim D, Kim K.

Dis Esophagus. 2013 Apr;26(3):272-5. doi: 10.1111/j.1442-2050.2012.01361.x. Epub 2012 May 29.

PMID:
22642487
9.

Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer.

Dolan JP, Kaur T, Diggs BS, Luna RA, Schipper PH, Tieu BH, Sheppard BC, Hunter JG.

Surg Endosc. 2013 Nov;27(11):4094-103. doi: 10.1007/s00464-013-3066-5. Epub 2013 Jul 12.

PMID:
23846365
10.
11.

An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer.

Nakamura M, Iwahashi M, Nakamori M, Ishida K, Naka T, Iida T, Katsuda M, Tsuji T, Nakatani Y, Yamaue H.

Langenbecks Arch Surg. 2008 Mar;393(2):127-33. Epub 2007 Dec 11.

PMID:
18071746
12.

[Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].

Chen G, Wang Z, Liu XY, Liu FY.

Ai Zheng. 2006 Jan;25(1):96-9. Chinese.

PMID:
16405760
13.

Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram.

Lagarde SM, Reitsma JB, Maris AK, van Berge Henegouwen MI, Busch OR, Obertop H, Zwinderman AH, van Lanschot JJ.

Ann Thorac Surg. 2008 Jun;85(6):1938-45. doi: 10.1016/j.athoracsur.2008.03.014.

PMID:
18498798
14.

Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma.

Swanson SJ, Batirel HF, Bueno R, Jaklitsch MT, Lukanich JM, Allred E, Mentzer SJ, Sugarbaker DJ.

Ann Thorac Surg. 2001 Dec;72(6):1918-24; discussion 1924-5.

PMID:
11789772
15.

Comorbidities and Risk of Complications After Surgery for Esophageal Cancer: A Nationwide Cohort Study in Sweden.

Backemar L, Lagergren P, Djärv T, Johar A, Wikman A, Lagergren J.

World J Surg. 2015 Sep;39(9):2282-8. doi: 10.1007/s00268-015-3093-6.

PMID:
25952691
16.

Influence of preoperative chemotherapy for advanced thoracic oesophageal squamous cell carcinoma on perioperative complications.

Hirao M, Ando N, Tsujinaka T, Udagawa H, Yano M, Yamana H, Nagai K, Mizusawa J, Nakamura K; Japan Esophageal Oncology Group/Japan Clinical Oncology Group.

Br J Surg. 2011 Dec;98(12):1735-41. doi: 10.1002/bjs.7683. Epub 2011 Sep 14.

PMID:
21918956
17.

Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.

Chen J, Pan J, Zheng X, Zhu K, Li J, Chen M, Wang J, Liao Z.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):475-82. doi: 10.1016/j.ijrobp.2010.08.037. Epub 2010 Oct 8.

PMID:
20934269
18.

Tracheobronchial lesions following esophagectomy: erosions, ulcers, and fistulae, and the predictive value of lymph node-related factors.

Maruyama K, Motoyama S, Sato Y, Hayashi K, Usami S, Minamiya Y, Ogawa J.

World J Surg. 2009 Apr;33(4):778-84. doi: 10.1007/s00268-008-9871-7.

PMID:
19127379
19.

Which factors are associated with extremely short-term survival after surgery in patients with esophageal squamous cell carcinoma?

Liu J, Wei Z, Zhang J, Hu W, Ma Z, Liu Q.

Asia Pac J Clin Oncol. 2016 Sep;12(3):308-13. doi: 10.1111/ajco.12503. Epub 2016 May 25.

PMID:
27220635
20.

Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes.

Suda K, Ishida Y, Kawamura Y, Inaba K, Kanaya S, Teramukai S, Satoh S, Uyama I.

World J Surg. 2012 Jul;36(7):1608-16. doi: 10.1007/s00268-012-1538-8.

PMID:
22392356

Supplemental Content

Support Center